To understand the molecular mechanisms underlying WNK1 dependency in AML, we focused on identifying downstream phosphorylation targets of the WNK1-OXSR1/STK39 pathway that could explain its role in AML. This evidence concerns the gene WNK1 and acute myeloid leukemia.